Free Trial
NASDAQ:OPGN

OpGen (OPGN) Stock Price, News & Analysis

OpGen logo
$4.78 +0.23 (+5.05%)
As of 07/11/2025 11:06 AM Eastern

About OpGen Stock (NASDAQ:OPGN)

Key Stats

Today's Range
$4.60
$4.78
50-Day Range
$4.50
$5.18
52-Week Range
$0.53
$5.25
Volume
214 shs
Average Volume
9,104 shs
Market Capitalization
$48.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OPGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OpGen and its competitors with MarketBeat's FREE daily newsletter.

OPGN Stock News Headlines

OpGen Forms Joint Venture with European Bank
This Cold War “Accident” Could Unleash New $100 Trillion AI Boom
Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.
OpGen Appoints New COO and Company Secretary
OPGN Stock Earnings: OpGen Reported Results for Q2 2024
See More Headlines

OPGN Stock Analysis - Frequently Asked Questions

OpGen's stock was trading at $0.5950 at the beginning of 2025. Since then, OPGN shares have increased by 703.4% and is now trading at $4.78.

OpGen, Inc. (NASDAQ:OPGN) announced its quarterly earnings results on Thursday, August, 10th. The medical research company reported ($9.30) earnings per share for the quarter, missing the consensus estimate of ($7.10) by $2.20. The medical research company earned $0.74 million during the quarter, compared to the consensus estimate of $0.90 million.

Shares of OpGen reverse split on Monday, May 20th 2024.The 1-10 reverse split was announced on Monday, May 20th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

OpGen (OPGN) raised $17 million in an IPO on Tuesday, May 5th 2015. The company issued 2,900,000 shares at a price of $5.50-$6.50 per share. Maxim Group served as the underwriter for the IPO and National Securities was co-manager.

Shares of OPGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that OpGen investors own include NVIDIA (NVDA), Meta Platforms (META), CymaBay Therapeutics (CBAY), Advanced Micro Devices (AMD), Pfizer (PFE), Sorrento Therapeutics (SRNE) and Broadcom (AVGO).

Company Calendar

Last Earnings
8/10/2023
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NASDAQ:OPGN
CIK
1293818
Employees
100
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$32.67 million
Net Margins
-1,140.36%
Pretax Margin
-742.42%
Return on Equity
N/A
Return on Assets
-287.58%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.45
Quick Ratio
5.45

Sales & Book Value

Annual Sales
$2.67 million
Price / Sales
18.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($11.55) per share
Price / Book
-0.41

Miscellaneous

Outstanding Shares
10,068,000
Free Float
4,696,000
Market Cap
$48.13 million
Optionable
Not Optionable
Beta
-1.66

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:OPGN) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners